back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-09-14 22:46 Tx date 2021-09-13 |
$NGEN
NervGen Pharma Corp. |
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$105,000
+50,000 vol $2.10 each |
300,000 | |
| Filed 2020-06-04 20:05 Tx date 2018-09-05 |
$NGEN
NervGen Pharma Corp. |
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,000
+100,000 vol $0.50 each |
200,000 | |
| Filed 2020-06-04 20:03 Tx date 2020-06-03 |
$NGEN
NervGen Pharma Corp. |
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$135,000
+50,000 vol $2.70 each |
250,000 | |
| Filed 2019-04-27 15:41 Tx date 2019-02-19 |
$NGEN
NervGen Pharma Corp. |
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2019-04-27 15:39 Tx date 2018-08-21 |
$NGEN
NervGen Pharma Corp. |
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-04-27 15:38 Tx date 2018-09-05 |
$NGEN
NervGen Pharma Corp. |
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,000
+100,000 vol $0.50 each |
||
| Filed 2019-03-01 13:06 Tx date 2018-09-05 |
$NGEN
NervGen Pharma Corp. |
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,000
+100,000 vol $0.50 each |
||
| Filed 2019-03-01 13:03 Tx date 2018-08-21 |
$NGEN
NervGen Pharma Corp. |
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-03-01 Tx date 2018-09-05 |
$
NervGen Pharma Corp. |
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,000
+100,000 vol $0.50 each |
100,000 | |
| Filed 2019-03-01 Tx date 2018-08-21 |
$
NervGen Pharma Corp. |
Abrams, Michael Jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|